The prevalence and concerns of polycystic ovary syndrome in young female university students aged 18–25 in Trinidad

2020 ◽  
Vol 14 (5) ◽  
pp. 1557-1558
Author(s):  
B.S. Nayak ◽  
Matthew Maharaj ◽  
Mitrani Maharaj ◽  
Nirvana Maharaj ◽  
Pooja Maharaj ◽  
...  
2022 ◽  
pp. 56-60
Author(s):  
E. V. Uvarova ◽  
E. P. Khashchenko ◽  
S. O. Kyurdzidi

This review is addressing an urgent problem of diagnosis and treatment strategy of polycystic ovary syndrome in adolescent girls. We analysed data from modern literary publications on the epidemiology and classification of the disease, as well as the adaptation of general principles for the management of young female patients tailored to their age peculiarities. The effective treatment strategies for adolescent girls with PCOS depending on its type are presented. Today there are several contradictions associated with both the diagnosis and treatment of the disease in the medical community. Thus, the use of the well-known Rotterdam criteria makes it difficult to diagnose PCOS in adolescent girls, since the criteria do not take into account characteristic changes that occur during puberty. Such manifestations as acne, hirsutism, menstrual irregularities, high androgen levels and morphology of polycystic ovaries on pelvic ultrasound imaging should be assessed with due account for age, puberty, hormonal balance with an assessment of the ratio of LH (luteinizing hormone)/FSH (follicle-stimulating hormone) and Free Androgen Index. There is no consensus in the medical community regarding the treatment strategy for PCOS. International communities have identified two main goals in the management of patients: normalization of menstrual function and improvement of the patients’ quality of life by preventing clinical symptoms of hyperandrogenism, and metabolic disorders of hyperplastic processes in target organs.Our analysis of objective scientific data showed that modern monophasic combined oral contraceptives (COCs) supplemented by of a folate component should be used to treat young female patients with PCOS, hyperandrogenism and psychosomatic disorders.


2005 ◽  
Vol 84 ◽  
pp. 1277-1284 ◽  
Author(s):  
Nozomi Tamura ◽  
Takumi Kurabayashi ◽  
Hiroshi Nagata ◽  
Hiroshi Matsushita ◽  
Tetsuro Yahata ◽  
...  

2020 ◽  
Vol 5 (04) ◽  
pp. 327-330
Author(s):  
Vivek Vilas Manade ◽  
C Sridevi

Abstract Polycystic ovary syndrome (PCOS) is known to cause weight gain, nonspecific inflammation, dyslipidemia, and coronary artery disease (CAD).Oral contraceptives (OCs) also cause venous and arterial thromboembolism, cerebrovascular accidents (CVA), and acute coronary syndrome (ACS). Myocardial infarction (MI) is comparatively less common in patients taking newer generation OCs, particularly if risk factors for CAD are absent, but the risk for venous thromboembolism is still high.Therefore, OCs should be considered in properly selected patients after weighing risks and benefits.


2021 ◽  
Vol 72 ◽  
pp. 103123
Author(s):  
Eman Alshdaifat ◽  
Amer Sindiani ◽  
Zouhair Amarin ◽  
Nadine Absy ◽  
Noor AlOsta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document